UC HEALTH LINE: Get the Facts on Diabetes Meds
University of Cincinnati (UC) diabetologist Barbara Ramlo-Halsted, MD, recommends talking with your physician before emptying your medicine cabinets.
News reports of adverse events and black-box warnings can cause alarm, but medications are often a useful tool for people managing their type 2 diabetes, says Ramlo-Halsted. And stopping use of a medicine without first consulting a physician can lead to unwanted complications.
Type 2 diabetes results from the bodys inability to properly use insulina hormone that converts sugar and other foods into energy within the body. If left unmanaged, diabetes can lead to vision loss, kidney failure, heart attack, stroke and nerve or blood vessel damage.
Some people are able to manage their diabetes through diet and exercise alone, but many need medications to improve the bodys ability to use the insulin that is produced, promote increased insulin production and/or reduce blood sugar.
Ramlo-Halsted recommends learning as much as you can about your diabetes and the medications you use to control it.
Understanding those medications and their potential side effects will allow you to be more knowledgeable about your own disease and can give you clues as to when, if ever, you need to seek medical attention, says Ramlo-Halsted.
The American Diabetes Association estimates that more than 23 million Americans have diabeteswith nearly 6 million of those cases yet to be diagnosed.
For more information about diabetes, visit www.netwellness.org, a collaborative health-information Web site staffed by
To schedule an appointment at UCs diabetes center, call (513) 475-8200.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.